Investment Rating - The report maintains a "Buy" rating for the industry [7] Core Insights - The optional consumption sector showed positive performance in the week of June 2-6, 2025, with the retail, social services, and beauty care sectors increasing by 1.29%, 2.09%, and 1.56% respectively, outperforming the Shanghai Composite Index which rose by 1.13% [15][17] - The beauty care segment saw significant growth, with Douyin's beauty category GMV reaching 23.497 billion yuan in May 2025, a year-on-year increase of 18% [3][23] - Major events included the acquisition of a 65% stake in Silky by Kids Wang for 1.65 billion yuan, and the IPO plans of several companies in the beauty and retail sectors [5][34] Market Performance - The retail, social services, and beauty care sectors ranked 15th, 9th, and 13th among 31 primary industries during the reporting week [15] - The tourism and beauty segments experienced notable gains, with the tourism sector seeing a 14.8% increase in domestic travel [26][27] Key Industry Data and News - In the beauty care sector, foreign brands dominated the top 10 beauty brands on Douyin, capturing 7 out of 10 spots [3][23] - The cultural and tourism sector reported a revenue of 14.151 trillion yuan in 2024, marking a 6% increase year-on-year [26] - The retail sector is witnessing significant developments, including the opening of Kids Wang's first ultra store in Shanghai and the successful IPO of Pitanium Limited on NASDAQ [5][34][29] Company Announcements - Kids Wang announced the acquisition of a 100% stake in Silky for 1.65 billion yuan, enhancing its market position [34] - Shanghai Jahwa revised its employee stock ownership plan to include revenue growth metrics [35] - The company Fat East reported a sales figure exceeding 10 billion yuan for the year [34][33]

近日，国家药监局在广州召开化妆品备案管理智能化转型工作视频会，会上强调围绕高水平安全、高质量发展、高效能治理的化妆品智能化转型方向，但同 时也提出要全面加强化妆品智慧监管能力建设，不断提升化妆品监管信息化、数字化和智能化水平。 化妆品生产与运营的智能化已经是行业大势所趋，以七大头部企业为例： 作者：苏苏 来源：首席消费官 以"药+妆"祛痘为核心理念的贝泰妮，构建了"AI诊断+个性化方案+私域服务"全链路； 华熙生物的AI战略则是通过"技术+生态+产业链"的三维布局，推动企业从生物制造向生物智造升级； 珀莱雅的布局则是以"技术+组织+全球化"为战略方向，企图构建科技驱动的美妆生态； 上海家化通过研发、定制化、数据资产三位一体，力争将技术优势转化为产品价值。 整体来看，国内头部美妆企业呈现拥抱AI的态度积极、AI应用场景多元、AI的应用到基础运营向高端开发跃迁、对于AI的投入从单一场景试水向生态布局 升级的现状。而此次监管的提示，也预示着美妆产业智能化将从野蛮生长向规范化路径转变。 从运营到研发 AI的深度技术融合 据年报披露，福瑞达2024年致力于推进理想皮肤微生态研究与AI数据模型开发，实施研发投入刚性增长机 ...

Market Performance - The market experienced a slight rebound last week, with the Shanghai Composite Index rising by 1.13%, the Shenzhen Component Index by 1.42%, and the ChiNext Index by 2.32% [2] - The China Securities News National Brand Engineering Index increased by 0.40%, closing at 1639.69 points [2] Strong Stock Performances - Notable strong performers in the National Brand Engineering Index included Zhongji Xuchuang, which rose by 10.58%, followed by Zhaoyi Innovation and Lanke Technology with increases of 9.92% and 9.85%, respectively [2] - Other significant gainers included Betaini (up 7.58%), and several stocks that rose over 6% such as Anji Technology and Weir Shares [2] Year-to-Date Stock Gains - Since the beginning of 2025, Xintai has seen a remarkable increase of 54.03%, leading the gains, followed by Marumi Bio at 43.43% and Shanghai Jahwa at 43.05% [3] - Other stocks with gains exceeding 20% include Weir Shares, Hada Group, and Lanke Technology [3] Market Outlook - Institutions maintain an optimistic view for the medium to long term, citing two main characteristics of the market: increased global volatility and strong resilience in the Chinese stock market [4] - Short-term market fluctuations are expected, with a gradual recovery indicating optimistic policy expectations and risk appetite [4] Investment Focus Areas - Key sectors to watch include AI applications, upstream resources, new consumption, and innovative pharmaceuticals, as these areas are expected to drive market performance [5] - The overall attractiveness of Chinese assets is highlighted, with improved economic expectations and confidence among private and foreign enterprises [5]

Core Insights - In 2024, China's total retail sales of consumer goods reached 48.79 trillion yuan, growing by 3.5%, marking the first time it fell below the GDP growth rate of 5% [1] - The fast-moving consumer goods (FMCG) industry is transitioning into a phase dominated by "stock competition," focusing on efficiency improvement, brand optimization, and structural adjustments [1] FMCG Company Performance - **Master Kong**: Achieved revenue of 806.51 billion yuan, a slight increase of 0.30%, with net profit rising by 19.80% to 37.34 billion yuan [2][6] - **Nongfu Spring**: Reported revenue of 428.96 billion yuan, up by 0.50%, and net profit of 121.23 billion yuan, a marginal increase of 0.40% [2][6] - **Uni-President**: Generated revenue of 303.32 billion yuan, a growth of 6.09%, with net profit of 18.49 billion yuan, increasing by 10.90% [2][6] - **China Foods**: Recorded revenue of 214.92 billion yuan, up by 0.20%, and net profit of 8.61 billion yuan, a growth of 3.40% [2][6] - **Eastroc Beverage**: Achieved significant growth with revenue of 158.39 billion yuan, up by 40.63%, and net profit of 33.27 billion yuan, increasing by 63.09% [2][6] - **Three Squirrels**: Reported revenue of 106.22 billion yuan, a substantial increase of 49.30%, with net profit rising by 85.51% to 4.08 billion yuan [2][6] Industry Trends - The FMCG sector is experiencing a shift towards efficiency and brand optimization as the era of rapid market growth driven by demographic dividends comes to an end [1] - Companies are adapting to market changes through product innovation, structural optimization, and brand rejuvenation to establish new growth curves and core competitiveness [13] - The beverage segment is seeing strong performance from Nongfu Spring's tea drinks, which have become a major revenue source despite challenges in the bottled water segment [8][13] - The snack segment is witnessing varied performance, with companies like Qinqin Foods achieving profitability through export and OEM manufacturing, while others like Liuyifei face challenges due to strategic adjustments [13] Dairy Industry Performance - **Yili Group**: Maintained its position as Asia's leading dairy company with revenue of 1,157.80 billion yuan, despite a decline of 8.24% [15][16] - **Mengniu Dairy**: Experienced a revenue drop of 10.09% to 886.75 billion yuan, with net profit significantly declining by 97.83% [15][16] - **Bright Dairy**: Reported revenue of 242.78 billion yuan, down by 8.33%, and net profit of 7.22 billion yuan, a decrease of 25.36% [15][16] - The dairy industry is facing challenges with supply-demand imbalances and declining consumer demand, leading to revenue declines for many traditional dairy giants [18]

Group 1 - The A-shares main indices opened slightly higher on June 5, with active performances in concepts such as virtual power plants, rare earths, EDA, and travel [1] - The A500 ETF fund (512050) rose by 0.11%, with its holding stock Wantai Biological Pharmacy opening at the daily limit, and other stocks like Shanghai Jahwa, Proya, and Xinwei Communication also rising [1] - The China Securities Index Co., Ltd. announced a periodic adjustment of sample stocks for several indices, including the CSI 300, CSI 500, and CSI 1000, effective after the market closes on June 13 [1] Group 2 - The CSI 500 index will replace 21 sample stocks, with new additions including Hunan Gold, Baile Tianheng, China National Pharmaceutical Group, and Hengxuan Technology, while stocks like Shengxin Lithium Energy, Jiuzhou Pharmaceutical, Golden Dragon Fish, and Shanshan Co. will be removed [1] - After the adjustment, the proportion of emerging industries in the CSI 500 index will be approximately 46.5%, further enhancing its representation of new productive forces [1] - Northeast Securities forecasts that June will see increased returns and win rates, with large-cap growth styles outperforming [2]

Investment Rating - The report maintains a "Buy" rating for Minth Group (425.HK) and Top Group (601689.CH) [2][4] - Top Group is given an "Accumulate" rating with a target price of 59.1 CNY [8] Core Insights - Minth Group is projected to achieve total revenue of 23.15 billion CNY in 2024, representing a year-on-year increase of 12.8%, with a net profit of 2.32 billion CNY, up 21.9% [2] - Top Group is expected to realize operating revenue of 26.6 billion CNY in 2024, a year-on-year increase of 35.02%, with a net profit of 3.001 billion CNY, up 39.52% [6][8] - Both companies are focusing on optimizing operational efficiency and expanding into new markets, including electric vehicle wireless charging and robotics [3][7] Summary by Sections Minth Group - The company has improved its gross margin to approximately 28.9%, up 1.5 percentage points year-on-year, driven by increased profitability in its plastic and battery box segments [2] - Cash flow has improved, allowing the company to resume dividends and share buybacks, reflecting management's confidence in future growth [4] Top Group - The company has faced challenges such as increased competition and raw material price fluctuations, but has managed to maintain a net profit margin of 11.3%, up 0.4 percentage points year-on-year [6] - Plans for capacity expansion include new factories in China and Mexico, with a focus on the rapidly growing robotics sector [7][8]

Group 1 - The number of equity incentive plans in the A-share market has been steadily increasing, with over 5,600 plans implemented involving more than 2,900 listed companies as of May 2025 [1][2] - Equity incentives are a crucial management tool that aligns employee interests with long-term company development, enhancing motivation and performance [2][4] - The majority of companies implementing equity incentives are concentrated in high-growth sectors such as technology, machinery, electronics, and pharmaceuticals, with over 300 companies in each of these industries [2][3] Group 2 - The ChiNext board shows the highest enthusiasm for equity incentives, with nearly 900 companies having implemented such plans, while over 1,500 companies on the Shanghai and Shenzhen main boards have done so [3] - Private enterprises are the main force behind equity incentive plans, with over 2,100 private listed companies participating, accounting for more than 72% of all companies with implemented plans [3][4] - Recent trends indicate a significant increase in the number of private companies adopting equity incentives, with over 81% of such companies implementing plans in 2024, a record high [4] Group 3 - The second type of restricted stock has become the mainstream incentive tool, with over 53% of companies choosing this option in 2024, marking a historical peak [4] - Performance assessment indicators are becoming more flexible and diverse, with companies incorporating unique metrics such as market capitalization and R&D capabilities into their evaluations [5] - Multi-phase incentive plans are becoming common, with several companies implementing more than ten equity incentive plans [5] Group 4 - Companies that have implemented equity incentives generally experience dual improvements in stock prices and performance, with median stock price increases outperforming the CSI 300 index by significant margins [6][7] - High-growth industries see particularly pronounced short-term stock price boosts following equity incentive announcements, while traditional sectors often show negative short-term excess returns [7] - The effectiveness of equity incentives tends to diminish over time, with a decreasing percentage of companies showing revenue and profit growth in subsequent years [8] Group 5 - A total of 25 companies are highlighted for their strong growth potential, with expectations for net profit growth exceeding 20% in the coming years, driven by high performance assessment targets [10][11] - Companies like Jingye Intelligent have set ambitious revenue growth targets, while Jinwo shares focus on net profit growth, indicating diverse strategies in performance incentives [11] - As of late May, these 25 companies have seen an average stock price increase of over 15%, significantly outperforming major indices, showcasing the positive impact of equity incentives on stock performance [11]

Core Viewpoint - The beauty brand Proya is entering the medical aesthetics market with its first medical device product, a collagen patch aimed at post-surgery recovery, as it seeks new growth avenues amid slowing growth of its main brand [1][3][5]. Company Summary - Proya has launched its first medical device product, the medical collagen patch, which is designed for post-surgery skin care [1][3]. - The product is priced at 163 yuan after discount, down from 198 yuan, and is targeted at various skin recovery scenarios [3]. - Proya's main brand revenue growth is slowing, with a reported revenue of 85.81 billion yuan in 2024, showing less than 20% growth compared to previous years [5][6]. - The company aims to achieve a revenue scale exceeding 100 billion yuan in 2024 and has set a goal to enter the top ten global cosmetics companies within the next decade [6][9]. Industry Summary - The medical aesthetics market in China is rapidly expanding, with a market size of approximately 266.9 billion yuan in 2023, projected to exceed 700 billion yuan by 2031 [3][4]. - Other domestic beauty brands, such as Shanghai Jahwa and Beitaini, are also entering the medical aesthetics space, indicating a competitive landscape [4]. - The medical aesthetics sector is still in a phase of complete competition, with no dominant brands yet established, presenting opportunities for new entrants like Proya [4][9]. - Proya's entry into the medical aesthetics market is seen as a necessary strategy to maintain growth and compete with international brands, which have stronger brand positioning and marketing capabilities [9].

Core Viewpoint - The company is responding to regulatory inquiries regarding its employee stock ownership plan, emphasizing that the plan is designed to align employee interests with company performance and does not constitute financial assistance to participants [1][2]. Group 1: Employee Stock Ownership Plan - The funding for the employee stock ownership plan comes from a long-term incentive fund, with a subscription price set at 16.03 yuan per share, sourced from shares repurchased in the secondary market [1][2]. - The plan aims to bind the interests of key employees to the company's long-term performance, encouraging them to achieve outstanding results and retain talent [2]. Group 2: Performance Assessment Criteria - The performance assessment criteria for the plan include achieving profitability in 2025 and a minimum net profit growth rate of 10% for 2026 and 2027, with no specific monetary targets set [3]. - The company has faced declining revenues over the past three years, with year-on-year decreases of 7.1%, 7.2%, and 13.9% from 2022 to 2024, and recorded a net loss of 830 million yuan in 2024 due to goodwill impairment [3]. Group 3: Revised Performance Indicators - The company plans to revise the performance indicators to include domestic revenue growth rates alongside net profit growth, aiming for a minimum of 10% growth in domestic revenue for 2025, 2026, and 2027 [4][5]. - The revised criteria will also require individual performance assessments for participants, ensuring that both company and personal performance metrics must be met for stock unlock [5]. Group 4: Selection of Participants - The plan includes two senior management personnel whose subscription shares account for 20.85% of the total plan, selected based on their significant contributions to the company's performance and long-term development [6][7]. - The roles of the selected senior management include overseeing daily operations and strategic decision-making, which are crucial for the company's long-term success [6][7].

Core Viewpoint - The company plans to appoint Ernst & Young Hua Ming as its new auditor for the 2025 fiscal year, replacing PwC Zhong Tian, to ensure the independence and objectivity of the audit process [1][7][8] Group 1: Auditor Change Details - The new auditor, Ernst & Young Hua Ming, was established in September 1992 and has over 1,700 certified public accountants, with more than 1,500 having experience in securities-related services [2][3] - Ernst & Young Hua Ming reported a total audited revenue of RMB 5.955 billion for 2023, with audit service revenue of RMB 5.585 billion and securities service revenue of RMB 2.438 billion [2] - The company plans to pay Ernst & Young Hua Ming a maximum of RMB 4.28 million for the 2025 financial statement and internal control audit, along with an additional RMB 400,000 for certain subsidiaries, totaling RMB 4.68 million [5][6] Group 2: Previous Auditor Information - The previous auditor, PwC Zhong Tian, provided audit services for 12 years and issued a standard unqualified opinion in the last audit [6][7] - The decision to change auditors was made to maintain the independence and objectivity of the audit process, following relevant regulations [7][8] Group 3: Approval Process - The audit committee and the board of directors have unanimously approved the appointment of Ernst & Young Hua Ming, with the board voting 9 in favor and none against [8] - The appointment is subject to approval at the company's 2025 annual shareholder meeting [2][8]